Perfecting Mice Models to Better Understand Prostate Cancer

Dr. Jim Xuan (1999, 2000 and 2002 Research Grants)

Mice are an important part of medical research because they are physiologically very similar to humans and have the same cancer incidence (30 per cent).

By creating genetically modified mice that mimic genetic alterations and human disease progression, scientists can test theories of causes and treatment of prostate cancer. The more closely a mouse model mimics human cancer, the faster it will lead to new treatments.

Dr. Jim Xuan has been awarded three Foundation grants for his work with mice models. In addition to developing new mouse models for prostate cancer, they have created a blood biomarker that helps monitor the initiation and progress of cancer in mice. They have also developed new three-dimensional technology that allows researchers to see what is happening inside the mice. Previously, the only way to evaluate effectiveness of therapy was during autopsy. Now researchers can see the effects of their interventions while mouse models are alive.




Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
12 innovative Canadian prostate cancer researchers set out to make new Discoveries

Toronto, ON – September 28, 2017: 12 forward-thinking Canadian prostate cancer researchers have been rewarded for their innovation with Movember Discovery Grants.
More

Gray Tools '2017 Together We Are Stronger' campaign a success in creating awareness and raising funds for prostate cancer

BRAMPTON, Ontario, Sept 26, 2017 (GLOBE NEWSWIRE) -- Gray Tools Canada Inc, in cooperation with Prostate Cancer Canada, is proud to announce that its “2017 Together We Are Stronger” initiative raised $4,000, which will go directly towards funding valuable research that is needed to improve the way we diagnose, treat, and support men living with the disease.
More

Rocco Rossi to wrap up successful 5-year tenure as Prostate Cancer Canada CEO

September 7, 2017 - TORONTO, ON - With mixed emotions, longstanding Prostate Cancer Canada (PCC) President and CEO, Rocco Rossi, formally announced today that his time leading the organization will officially come to a close as of December 31, 2017.
More


Click here for news archive